These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31205267)

  • 1. A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan.
    Owada Y; Oshiro Y; Inagaki Y; Harada H; Fujiyama N; Kawagishi N; Yagisawa T; Usui J; Akutsu N; Itabashi Y; Saito K; Watarai Y; Ichimaru N; Imamura R; Kyakuno M; Ide K; Shibuya Y; Okabe Y; Ono M; Sasaki K; Shiose A; Yamagishi K; Ohnishi H; Nagashima S; Takahashi M; Yuzawa K; Okamoto H; Ohkohchi N
    Transplantation; 2020 Feb; 104(2):437-444. PubMed ID: 31205267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan.
    Inagaki Y; Oshiro Y; Tanaka T; Yoshizumi T; Okajima H; Ishiyama K; Nakanishi C; Hidaka M; Wada H; Hibi T; Takagi K; Honda M; Kuramitsu K; Tanaka H; Tohyama T; Ikegami T; Imura S; Shimamura T; Nakayama Y; Urahashi T; Yamagishi K; Ohnishi H; Nagashima S; Takahashi M; Shirabe K; Kokudo N; Okamoto H; Ohkohchi N
    EBioMedicine; 2015 Nov; 2(11):1607-12. PubMed ID: 26870785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
    Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
    Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy.
    Scotto G; Aucella F; Grandaliano G; Martinelli D; Querques M; Gesuete A; Infante B; Carri PD; Massa S; Salatino G; Bulla F; Fazio V
    World J Gastroenterol; 2015 Mar; 21(11):3266-73. PubMed ID: 25805933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis E virus of subtype 3i in chronically infected kidney transplant recipients in southeastern France.
    Moal V; Gérolami R; Ferretti A; Purgus R; Devichi P; Burtey S; Colson P
    J Clin Microbiol; 2014 Nov; 52(11):3967-72. PubMed ID: 25187634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis E virus RNA and antibodies in a cohort of kidney transplant recipients in Central Brazil.
    de Oliveira JMNS; Freitas NR; Teles SA; Bottino FO; Lemos AS; de Oliveira JM; de Paula V; Pinto MA; Martins RMB
    Int J Infect Dis; 2018 Apr; 69():41-43. PubMed ID: 29408465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation.
    Unzueta A; Valdez R; Chang YH; Desmarteau YM; Heilman RL; Scott RL; Douglas DD; Rakela J
    Ann Hepatol; 2016; 15(1):33-40. PubMed ID: 26626638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis.
    Hansrivijit P; Trongtorsak A; Puthenpura MM; Boonpheng B; Thongprayoon C; Wijarnpreecha K; Choudhury A; Kaewput W; Mao SA; Mao MA; Jadlowiec CC; Cheungpasitporn W
    World J Gastroenterol; 2021 Mar; 27(12):1240-1254. PubMed ID: 33828397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric liver transplanted patients and prevalence of hepatitis E virus.
    Laverdure N; Scholtès-Brunel C; Rivet C; Heissat S; Restier L; Bacchetta J; Boillot O; Dumortier J; Lachaux A
    J Clin Virol; 2015 Aug; 69():22-6. PubMed ID: 26209371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E infection in stem cell and solid organ transplantpatients: A cross-sectional study: The importance of HEV RNA screening in peri-transplant period.
    Reekie I; Irish D; Ijaz S; Fox T; Bharucha T; Griffiths P; Thorburn D; Harber M; MacKinnon S; Sekhar M
    J Clin Virol; 2018 Oct; 107():1-5. PubMed ID: 30099145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis E in liver transplant recipients in Greece.
    Sinakos Ε; Gioula G; Liava C; Papa A; Papadopoulou E; Tsakni E; Fouzas I; Akriviadis E
    Epidemiol Infect; 2018 Oct; 146(13):1619-1621. PubMed ID: 29974836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report and molecular characterization of hepatitis E virus infection in renal transplant recipients in Brazil.
    Passos AM; Heringer TP; Medina-Pestana JO; Ferraz ML; Granato CF
    J Med Virol; 2013 Apr; 85(4):615-9. PubMed ID: 23382036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past and current hepatitis E virus infection in renal transplant patients.
    Hering T; Passos AM; Perez RM; Bilar J; Fragano D; Granato C; Medina-Pestana JO; Ferraz ML
    J Med Virol; 2014 Jun; 86(6):948-53. PubMed ID: 24619955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients--a single-center experience.
    Hoerning A; Hegen B; Wingen AM; Cetiner M; Lainka E; Kathemann S; Fiedler M; Timm J; Wenzel JJ; Hoyer PF; Gerner P
    Pediatr Transplant; 2012 Nov; 16(7):742-7. PubMed ID: 22738211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients.
    Rossi-Tamisier M; Moal V; Gerolami R; Colson P
    J Clin Virol; 2013 Jan; 56(1):62-4. PubMed ID: 23089569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.
    Pischke S; Suneetha PV; Baechlein C; Barg-Hock H; Heim A; Kamar N; Schlue J; Strassburg CP; Lehner F; Raupach R; Bremer B; Magerstedt P; Cornberg M; Seehusen F; Baumgaertner W; Klempnauer J; Izopet J; Manns MP; Grummer B; Wedemeyer H
    Liver Transpl; 2010 Jan; 16(1):74-82. PubMed ID: 19866448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single-Center Experience.
    Carter M; Solsrud K; Yeddula S; Fitzmaurice MG; Singh A; Nagai S; Jafri SM
    Transplant Proc; 2022 Sep; 54(7):1737-1741. PubMed ID: 35907694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients.
    Ankcorn MJ; Ijaz S; Poh J; Elsharkawy AM; Smit E; Cramb R; Ravi S; Martin K; Tedder R; Neuberger J
    Transplantation; 2018 Jul; 102(7):1139-1147. PubMed ID: 29953421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.